Largest psilocybin trial finds the psychedelic is effective in treating serious depression. “29.1% of patients in the highest-dose group were in remission three weeks after treatment, compared to 7.6% of those in the control group.”
Advertise here with Carbon Ads
This site is made possible by member support. 💞
Big thanks to Arcustech for hosting the site and offering amazing tech support.
When you buy through links on kottke.org, I may earn an affiliate commission. Thanks for supporting the site!
kottke.org. home of fine hypertext products since 1998.
Beloved by 86.47% of the web.
Socials & More